Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0037144 (Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs